Jim Simons Larimar Therapeutics, Inc. Transaction History

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Larimar Therapeutics, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 353,842 shares of LRMR stock, worth $1.42 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

353,842

Previous 278,342 27.12%

Holding current value

$1.42 Million

Previous $2.02 Million 14.87%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$6.3 - $10.68 $475,650 - $806,340	75,500 Added 27.12%	353,842 $2.32 Million
Q2 2024 Aug 09, 2024	SELL	$6.33 - $9.89 $1.42 Million - $2.23 Million	-225,100 Reduced 44.71%	278,342 $2.02 Million
Q1 2024 May 13, 2024	BUY	$4.2 - $13.28 $1.08 Million - $3.4 Million	256,400 Added 103.79%	503,442 $3.82 Million
Q4 2023 Feb 13, 2024	BUY	$2.35 - $4.71 $3,995 - $8,007	1,700 Added 0.69%	247,042 $1.12 Million
Q3 2023 Nov 14, 2023	SELL	$3.08 - $4.49 $111,594 - $162,681	-36,232 Reduced 12.87%	245,342 $969,000
Q2 2023 Aug 11, 2023	BUY	$3.13 - $5.27 $309,344 - $520,844	98,832 Added 54.08%	281,574 $881,000
Q1 2023 May 12, 2023	SELL	$4.0 - $6.68 $184,128 - $307,493	-46,032 Reduced 20.12%	182,742 $828,000
Q4 2022 Feb 13, 2023	SELL	$2.73 - $5.08 $184,528 - $343,372	-67,593 Reduced 22.81%	228,774 $945,000
Q3 2022 Nov 14, 2022	BUY	$1.53 - $3.64 $184,862 - $439,803	120,825 Added 68.83%	296,367 $948,000
Q2 2022 Aug 12, 2022	BUY	$1.9 - $3.98 $5,320 - $11,144	2,800 Added 1.62%	175,542 $344,000
Q1 2022 May 13, 2022	SELL	$3.65 - $10.84 $73,116 - $217,146	-20,032 Reduced 10.39%	172,742 $700,000
Q4 2021 Feb 11, 2022	SELL	$8.86 - $13.47 $474,009 - $720,645	-53,500 Reduced 21.72%	192,774 $2.08 Million
Q3 2021 Nov 12, 2021	BUY	$9.61 - $15.11 $485,305 - $763,055	50,500 Added 25.8%	246,274 $2.84 Million
Q2 2021 Aug 13, 2021	SELL	$8.0 - $15.2 $133,600 - $253,840	-16,700 Reduced 7.86%	195,774 $1.92 Million
Q1 2021 May 13, 2021	SELL	$14.61 - $22.19 $130,029 - $197,491	-8,900 Reduced 4.02%	212,474 $3.1 Million
Q4 2020 Feb 10, 2021	BUY	$14.28 - $25.06 $318,444 - $558,838	22,300 Added 11.2%	221,374 $4.74 Million
Q3 2020 Nov 13, 2020	SELL	$10.5 - $17.6 $99,750 - $167,200	-9,500 Reduced 4.55%	199,074 $3.02 Million
Q2 2020 Aug 13, 2020	BUY	$0.72 - $16.76 $150,173 - $3.5 Million	208,574 New	208,574 $2.68 Million

Others Institutions Holding LRMR

# of Institutions

128

Shares Held

67.3M

Call Options Held

280K

Put Options Held

76.3K

View Full List

About Larimar Therapeutics, Inc.

Ticker LRMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,269,200
Market Cap $174M
Description
Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 1 clinical trial for the treatment of Friedreich's ataxia, a rare, progressive, and fatal genetic disease. T...

More about LRMR

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account